Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Financing Activities: 2013-2018

Historic Cash from Financing Activities for Armata Pharmaceuticals (ARMP) over the last 4 years, with Dec 2018 value amounting to $6.1 million.

  • Armata Pharmaceuticals' Cash from Financing Activities rose 3055.83% to $6.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $12.5 million, marking a year-over-year increase of 43.59%. This contributed to the annual value of $35.0 million for FY2024, which is 35.25% down from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Cash from Financing Activities of $6.1 million as of Q4 2018, which was up 13,938.64% from -$44,000 recorded in Q3 2018.
  • In the past 5 years, Armata Pharmaceuticals' Cash from Financing Activities registered a high of $12.4 million during Q1 2015, and its lowest value of -$611,000 during Q3 2017.
  • Its 3-year average for Cash from Financing Activities is $2.4 million, with a median of -$30,500 in 2016.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first slumped by 3,494.12% in 2017, then skyrocketed by 3,324.39% in 2018.
  • Quarterly analysis of 4 years shows Armata Pharmaceuticals' Cash from Financing Activities stood at -$1,000 in 2015, then slumped by 1,600.00% to $3.3 million in 2016, then crashed by 106.33% to -$206,000 in 2017, then surged by 3,055.83% to $6.1 million in 2018.
  • Its Cash from Financing Activities stands at $6.1 million for Q4 2018, versus -$44,000 for Q3 2018 and -$204,000 for Q2 2018.